No. As of now, there is no reason to panic. Dr Jayadevan, Co-Chairman of the National Indian Medical Association (IMA) Covid Task Force in Kerala, told ANI that TTS is a rare occurrence following specific types of vaccines and other causes. Most cases of TTS are reported within a few weeks of vaccination. Therefore, staying vigilant and consulting a doctor if you experience any symptoms of TTS is advisable.
AstraZeneca developed the COVID-19 vaccine in collaboration with Oxford University. Both vaccines are identical in formulation but are manufactured and distributed in different geographical locations. AstraZeneca’s vaccine is categorised as an adenovirus vector vaccine and has shown 60–80% protection against COVID-19 infection in clinical trials.
It is also to be noted that TTS is linked to other COVID-19 vaccines as well. Johnson & Johnson’s COVID-19 vaccine, named Janssen, has also been associated with this condition. According to a 2023 report by Yale Medicine haematologist Robert Bona, MD, TTS typically occurs in individuals who are bedridden, hospitalised or have other medical issues related to inflammation, infection, or cancer
Read also: After Covishield vaccine side effects disclosed, grieving parents move to court against Serum Institute of India